Skip to content

Clinical trials

Phase 2 Arthritis, Rheumatoid trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arthritis, Rheumatoid Phase: Phase 2 Country / region: China Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20071
20142
20152
20172
20192
20213
20224
20233
20241
20254
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting6
Terminated4
Unknown status2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong5
Peking University People's Hospital4
Hangzhou Highlightll Pharmaceutical Co., Ltd2
Peking Union Medical College Hospital2
AstraZeneca1
BeiGene1
Beijing VDJBio Co., LTD.1
Changchun GeneScience Pharmaceutical Co., Ltd.1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arthritis, Rheumatoid32
Arthritis1
Autoimmune Diseases1
Connective Tissue Diseases1
Hereditary Sensory and Autonomic Neuropathies1
Immune System Diseases1
Joint Diseases1
Lymphoma, Follicular1
Musculoskeletal Diseases1
Rheumatic Diseases1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.